Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

Mohammad Raeiszadeh, Annette Pachnio, Jusnara Begum, Charles Craddock, Paul Moss, Frederick E Chen

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)e318-22
Issue number8
Publication statusPublished - Aug 2015

Cite this